Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Completed 21Unknown 20Recruiting 7Terminated 6Active not recruiting 5Withdrawn 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5Gastrointestinal 3

Conditions

Ovarian Neoplasms 3Carcinoma, Ovarian Epithelial 2Stomach Neoplasms 1Peritoneal Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Fallopian Tube Neoplasms 1

Interventions

pembrolizumab 45Paclitaxel 45Carboplatin 39Magnetic Resonance Spectroscopy 28olaparib 27Specimen Handling 26Cisplatin 24Bevacizumab 20Nivolumab 18Taxes 17Biopsy 16Gemcitabine 13Cyclophosphamide 13durvalumab 12Immunoglobulin G 11Doxorubicin 11Disulfides 11Surveys and Questionnaires 10niraparib 9liposomal doxorubicin 9dostarlimab 9Radiotherapy 8Brachytherapy 8lenvatinib 7fludarabine 7atezolizumab 7Letrozole 7Docetaxel 7cediranib 6Platinum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Hyperthermic Intraperitoneal Chemotherapy × Gynecologic × Clear all
NCT01376752 2026-05-20

CHIPOR

UNICANCER

Phase 3 Active not recruiting
415 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT03842982 2026-03-16

CHIPPI

Centre Oscar Lambret

Phase 3 Active not recruiting
362 enrolled
Gynecologic

Ovarian Neoplasms

NCT05316181 2026-02-12

KOV-HIPEC-02R

National Cancer Center, Korea

Phase 3 Active not recruiting
140 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT03348150 2025-07-17

PERISCOPEII

The Netherlands Cancer Institute

Phase 3 Active not recruiting
102 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT02124421 2024-11-19

CRS/HIPEC

Mercy Medical Center

Phase 2 Active not recruiting
32 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡